Sedana Medical's AnaConDa approved to be used in children
Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company's medical device AnaConDa, for the administration of volatile anesthetics for sedation of mechanically ventilated intensive care patients, has received approval for use on children by the European notifying body BSI Group. The approval also means that AnaConDa can be used in patients with severely impaired lung capacity."This means that we have no restrictions on the use of AnaConDa and that we can reach the entire market for mechanically ventilated intensive care patients. Regardless of whether you are a child,